Dr. Lal Pathlabs Ltd (NSE: LALPATHLAB) and Vijaya Diagnostic Centre Limited (NSE: VIJAYA) are both listed in the Medical Diagnostic Centres industry. Dr. Lal Pathlabs has a market capitalisation of ₹31,567 Cr and Vijaya Diagnostic Centre ₹15,011 Cr, as of 9 Nov 2026. Their P/E ratios are 62.5 and 86.8 respectively. Return on equity is 21.48% for Dr. Lal Pathlabs and 19.70% for Vijaya Diagnostic Centre. Over one year, Dr. Lal Pathlabs's share price is up 24.2% and Vijaya Diagnostic Centre's is up 49.7%.
| Metric | Dr. Lal Pathlabs | Vijaya Diagnostic Centre |
|---|---|---|
| NSE Symbol | LALPATHLAB | VIJAYA |
| BSE Code | 539524 | 543350 |
| Share Price | ₹2,020.60 | ₹1,480.00 |
| Market Cap | ₹31,567 Cr | ₹15,011 Cr |
| P/E Ratio | 62.5 | 86.8 |
| Return on Equity | 21.48% | 19.70% |
| Return on Assets | 13.34% | 11.02% |
| Dividend Yield | 1.06% | 0.14% |
| Beta (1Y) | 0.61 | 0.83 |
| 1-Year Price Change | +24.2% | +49.7% |
| 3-Month Price Change | +3.4% | +6.3% |
| 52-Week Range | ₹1,272.60 – ₹2,079.00 | ₹848.00 – ₹1,593.60 |
| Latest Quarter | Q2 FY27 | Q2 FY27 |
| Quarterly Revenue | ₹874 Cr | ₹255 Cr |
| Quarterly Net Profit | ₹194 Cr | ₹59 Cr |
| Net Margin | 22.2% | 23.3% |
| EPS (Basic, Quarter) | ₹11.51 | ₹5.78 |
| Results Basis | consolidated | consolidated |
| Headquarters | Gurugram, Haryana | Hyderabad, Telangana |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
Dr. Lal Pathlabs has a market capitalisation of ₹31,567 Cr, against ₹15,011 Cr for Vijaya Diagnostic Centre as of 9 Nov 2026, about 2.1 times the size by market cap.
Dr. Lal Pathlabs has a P/E of 62.5 and Vijaya Diagnostic Centre a P/E of 86.8 as of 9 Nov 2026.
Dr. Lal Pathlabs has a return on equity of 21.48% and Vijaya Diagnostic Centre 19.70%.
Dr. Lal Pathlabs's share price is up 24.2% over one year and Vijaya Diagnostic Centre's is up 49.7%.
Dr. Lal Pathlabs reported revenue of ₹874 Cr and net profit of ₹194 Cr for Q2 FY27. Vijaya Diagnostic Centre reported revenue of ₹255 Cr and net profit of ₹59 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Services > Medical Diagnostic Centres on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.